nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0947	0.1	CcSEcCtD
Regadenoson—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0775	0.0821	CcSEcCtD
Regadenoson—Adenosine monophosphate—APRT—nephrolithiasis	0.0561	1	CrCbGaD
Regadenoson—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0552	0.0585	CcSEcCtD
Regadenoson—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0426	0.0451	CcSEcCtD
Regadenoson—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0366	0.0388	CcSEcCtD
Regadenoson—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0345	0.0365	CcSEcCtD
Regadenoson—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0274	0.029	CcSEcCtD
Regadenoson—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0263	0.0279	CcSEcCtD
Regadenoson—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0207	0.022	CcSEcCtD
Regadenoson—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0206	0.0219	CcSEcCtD
Regadenoson—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0208	CcSEcCtD
Regadenoson—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0181	CcSEcCtD
Regadenoson—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0165	0.0175	CcSEcCtD
Regadenoson—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0158	CcSEcCtD
Regadenoson—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0158	CcSEcCtD
Regadenoson—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0157	CcSEcCtD
Regadenoson—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0147	CcSEcCtD
Regadenoson—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0143	CcSEcCtD
Regadenoson—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0134	CcSEcCtD
Regadenoson—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0134	CcSEcCtD
Regadenoson—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0125	CcSEcCtD
Regadenoson—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0123	CcSEcCtD
Regadenoson—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0118	CcSEcCtD
Regadenoson—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0117	CcSEcCtD
Regadenoson—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.011	0.0116	CcSEcCtD
Regadenoson—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0115	CcSEcCtD
Regadenoson—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0113	CcSEcCtD
Regadenoson—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0112	CcSEcCtD
Regadenoson—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0111	CcSEcCtD
Regadenoson—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0104	0.011	CcSEcCtD
Regadenoson—Cough—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0109	CcSEcCtD
Regadenoson—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0107	CcSEcCtD
Regadenoson—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0107	CcSEcCtD
Regadenoson—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0107	CcSEcCtD
Regadenoson—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.01	0.0106	CcSEcCtD
Regadenoson—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00996	0.0105	CcSEcCtD
Regadenoson—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0102	CcSEcCtD
Regadenoson—Shock—Hydrochlorothiazide—nephrolithiasis	0.0095	0.0101	CcSEcCtD
Regadenoson—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00943	0.00999	CcSEcCtD
Regadenoson—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00934	0.00989	CcSEcCtD
Regadenoson—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00903	0.00956	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0088	0.00932	CcSEcCtD
Regadenoson—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00874	0.00926	CcSEcCtD
Regadenoson—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00867	0.00919	CcSEcCtD
Regadenoson—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00861	0.00912	CcSEcCtD
Regadenoson—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00859	0.0091	CcSEcCtD
Regadenoson—Pain—Hydrochlorothiazide—nephrolithiasis	0.00826	0.00875	CcSEcCtD
Regadenoson—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00796	0.00843	CcSEcCtD
Regadenoson—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0079	0.00837	CcSEcCtD
Regadenoson—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00767	0.00813	CcSEcCtD
Regadenoson—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00764	0.00809	CcSEcCtD
Regadenoson—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00712	0.00754	CcSEcCtD
Regadenoson—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00734	CcSEcCtD
Regadenoson—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00661	0.007	CcSEcCtD
Regadenoson—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00639	0.00677	CcSEcCtD
Regadenoson—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00651	CcSEcCtD
Regadenoson—Rash—Hydrochlorothiazide—nephrolithiasis	0.00609	0.00645	CcSEcCtD
Regadenoson—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00645	CcSEcCtD
Regadenoson—Headache—Hydrochlorothiazide—nephrolithiasis	0.00605	0.00641	CcSEcCtD
Regadenoson—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00608	CcSEcCtD
